Alterations of HLA class I molecules, as well as HLA-G and HLA-E, on B cells are of potential interest, as they could represent a putative escape mechanism of neoplastic clone B from CTL and NK recognition in CLL patients with stable disease. The gene discussed is HLA-G; the disease is B-cell chronic lymphocytic leukemia.